Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer

Ovarian cancer (OC) has the highest mortality rate of any gynecologic cancer, and patients generally have a poor prognosis due to high chemotherapy resistance and late stage disease diagnosis. Platinum-resistant OC can be treated with cytotoxic chemotherapy such as paclitaxel, topotecan, pegylated l...

Descripción completa

Detalles Bibliográficos
Autores principales: Leamon, Christopher P, Lovejoy, Chandra D, Nguyen, Binh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792616/
https://www.ncbi.nlm.nih.gov/pubmed/24109193
http://dx.doi.org/10.2147/PGPM.S24943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792616/
https://www.ncbi.nlm.nih.gov/pubmed/24109193
http://dx.doi.org/10.2147/PGPM.S24943

Ejemplares similares